Thank you for contacting me about animal research and ethical innovation.
I share the Government's commitment to the development of alternatives to using animals in scientific procedures and I am glad the Government continues to actively support and fund the development and dissemination of the 3Rs (replacement, reduction and refinement) for the use of animals in scientific procedures.
This is achieved through UK Research and Innovation’s funding of the National Centre for the 3Rs, which works nationally and internationally to drive the uptake of non-animal technologies, and through research into the development of alternatives by Innovate UK, the Medical Research Council, and the Biotechnology and Biological Sciences Research Council.
I understand that with regard to animal testing for cosmetics the Government has recognised the public concern around the testing on animals of chemicals used as ingredients in cosmetics. I welcome the fact that the Government has introduced measures that ensure no new licences will now be granted for animal testing of chemicals that are exclusively intended to be used as ingredients in cosmetics products. Further, I am aware the Government is also undertaking a review at pace on the effective administration of the ban over the longer term. This will give due regard of the needs of the science industry, the need to ensure worker and environmental safety, and the need to protect animals from unnecessary harm.
More broadly, I am glad that the Government is actively committed to supporting and funding the development and dissemination of techniques that replace, reduce and refine the use of animals in research (the 3Rs). This is primarily through funding from the UK Research and Innovation for the National Centre for the 3Rs (NC3Rs) who have committed £31.6 million for research and innovation into replacements technologies in the past five years, and to ensure that the UK has a robust and regulatory system for licensing animal studies. The NC3Rs are on tract to meet their commitment to invest 75 per cent of their research and innovation budge on replacement technologies by the end of 2024.
From article posted January 2024